GLP1R and chronic kidney disease: GLP-1 receptor agonists (GLP-1RAs) are anti-diabetic agents with the potential to decelerate the progression of chronic kidney disease (CKD) by inhibiting oxidative stress, fibrosis, and apoptosis [104].